VR Logo

Ipca Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1949

Chairman: Premchand Godha

Managing Director: Premchand Godha

Group: Ipca Laboratories

Listing: NSE: IPCALAB, BSE: 524494

Headquarters: Mumbai, Maharashtra

Website: www.ipcalabs.com

Key Facts

Market cap: R 27,365.17 Cr

Revenue (TTM): R 5,379.09 Cr

Earnings (TTM): R 1,070.54 Cr

Cash: R 419.17 Cr

Total Debt: R 481.83 Cr

Promoters' ownership: 46.29%

Liquidity: High

52 Week range: R 1,462.65 - 2,460.00

Face value: R2.00

Shares outstanding: 12,68,52,109

10 Years Aggregate:

  • CFO: 4,344.31 Cr
  • EBITDA: 5,230.80 Cr
  • Net Profit: 3,198.24 Cr

Stock Performance

Time Period Ipca Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD-1.517.8710.73
1 month17.2113.83-0.89
3 months2.546.873.70
1 Year43.3256.9368.37
3 Years45.4519.145.74
5 Years34.428.4712.41
10 Years21.3814.2610.63
As on 20-Apr-2021
Year Ipca Laboratories S&P BSE Mid Cap S&P BSE Healthcare
202092.2819.8761.45
201939.19-3.05-3.55
201833.85-13.31-5.89
201712.2448.130.49
2016-28.197.97-12.88
20152.957.4315.06
20141.3254.6947.43